[Diagnosis of and therapy for fulminant type 1 diabetes mellitus].
Imakawa
Akihisa
A
Hanafusa
Toshiaki
T
D015415:Biomarkers / Q000032:analysis; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D016883:Diabetic Ketoacidosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D042241:Early Diagnosis; D006442:Glycated Hemoglobin / Q000032:analysis; D015804:HLA-DR4 Antigen / Q000235:genetics; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D050417:Insulin-Secreting Cells / Q000276:immunology / Q000473:pathology; D007564:Japan / Q000453:epidemiology; D015810:Linkage Disequilibrium; D011379:Prognosis; D018417:Th1 Cells / Q000276:immunology; D013997:Time Factors; D014777:Virus Diseases / Q000150:complications
D015415:Biomarkers; D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D015804:HLA-DR4 Antigen; D007328:Insulin